RegeneRx News
Most Popular RegeneRx Story
RegeneRx refocuses development program
RegeneRx said that based on encouraging "compassionate use" data showing RGN-259's potential healing effects in patients with non-healing corneal ulcers, the company will close its current Phase II Read more...
Latest Headlines
- April 14, 2011
- April 13, 2009
- January 21, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
